MITC the next Beyond Meat ???

Dec. 7, 2021 Sharon Fima, CEO and CTO, MeaTech3D:

“Today’s breakthrough is the culmination of over one year’s efforts in our cellular biology and high-throughput tissue engineering processes, as well as our precision bioprinting technology. By bioprinting a 3.67 oz steak comprised of living tissue, we believe we have both validated our core technologies and placed ourselves at the forefront of the race to develop high-end, real cell-based cultivated premium meat products.”

I think MeaTech3D has the potential to rival BYND at some point.

52 Week Range 4.81 - 11.79

Market Cap of only 84.347M